AztraZeneca is tapping the power of crowdsourcing to identify potent cocktails that can lead to the development of new cancer drugs. The pharmaceutical company will release preclinical data from more than 50 of its medicines.
AztraZeneca is tapping the power of crowdsourcing to identify potent cocktails that can lead to the development of new cancer drugs. The pharmaceutical company will release preclinical data from more than 50 of its medicines.
Share this Article
Recommended